Peptide medicine has become one of the most discussed areas in health optimisation. That attention creates opportunity, but also noise. Different peptides have different biological actions, evidence, indications, safety considerations and regulatory status. They should not be treated as one interchangeable category.
Dr Luhard provides medically supervised peptide consultations at Medify in Waterkloof, Pretoria. His clinical focus is to understand the patient’s objective, decide whether peptide-based treatment has a rational role and explain the limitations as clearly as the potential benefits.
What are peptides?
Peptides are short chains of amino acids. Many occur naturally in the body and act as signalling molecules. The word “peptide” therefore describes a type of molecule, not a single treatment. Each compound must be assessed on its own clinical evidence and safety profile.
Some peptide-based medicines are established in conventional medical practice, while other compounds are still emerging or have limited human evidence. A responsible consultation distinguishes between these categories rather than presenting all peptide options as equally proven.
Clinical rule: a peptide should never be selected simply because it is popular. The indication, evidence, patient and monitoring plan must make sense together.
Dr Luhard’s clinical framework
A peptide medicine consultation is guided by four questions:
- What is the medical objective? The intended outcome must be specific enough to assess.
- Is this patient suitable? Medical history, current treatment, contraindications and baseline risk matter.
- What is the quality of evidence? Claims should be separated from meaningful clinical data.
- How will response be monitored? Symptoms, measurements, laboratory results or other agreed outcomes may be relevant.
If these questions cannot be answered responsibly, treatment should not proceed.
What happens during a peptide consultation?
The consultation starts with the reason for seeking treatment and a review of the broader health context. Relevant aspects may include current diagnoses, medication, previous treatment, blood results, symptoms, lifestyle and the patient’s expectations.
Dr Luhard then explains whether a peptide-based option appears clinically reasonable, what is known and not known, the expected follow-up and possible alternatives. The consultation may conclude that no peptide treatment is suitable.
Patient education
Patients should understand the intended goal, the limitations of the available evidence and the importance of medical follow-up. Clear education helps prevent peptide medicine from becoming a collection of unsupported promises.
Clinical monitoring
Monitoring should match the reason for treatment. Depending on the clinical context, this may include symptom review, physical measurements, laboratory investigations or another defined outcome. Continuing treatment without assessing response is not a meaningful medical plan.
Safety and regulatory context
Regulatory status and quality assurance differ between peptide compounds and jurisdictions. Medical supervision does not remove uncertainty, but it creates a structured process for discussing it and deciding what is reasonable for the individual.
Patients should not self-source, self-prescribe or use dosing advice from social media. A face-to-face or appropriately conducted medical consultation is required before considering any prescription-based care.
Clinical practice and doctor education
Dr Luhard is the founder of Medify and co-founder of MedBase. He treats patients in clinical practice and contributes to structured medical education for healthcare professionals. His teaching work includes the practical and responsible integration of peptide medicine into clinical care.
This dual role matters: educating doctors requires a clear view of evidence, risk and implementation—not only a list of products. It is the same standard brought into patient consultations.
Peptide consultations in Waterkloof, Pretoria
Consultations take place at Medify, 265 Main Street, Waterkloof, Pretoria, Gauteng. WhatsApp 065 559 5412 to request availability. Prescription treatment is only considered after medical assessment and where clinically appropriate.
Ask the right questions first.
Request a medically supervised peptide consultation with Dr Luhard in Pretoria.